focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 17.80
Ask: 19.60
Change: -0.35 (-1.84%)
Spread: 1.80 (10.112%)
Open: 19.05
High: 0.00
Low: 0.00
Prev. Close: 19.05
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 Nov 2009 07:00

3 November 2009 LMS Capital plc Interim Management Statement

LMS Capital plc ("LMS Capital" or "the Company") presents its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement relates to the period from 1 July 2009 to 31 October 2009.

LMS Capital is an international investment company which aims to produce high rates of return though a risk diversified portfolio. This diversification is achieved through geographical spread, primarily the US and UK, and through investment in assets of varying maturities. The major focus is in small to medium sized companies in our preferred sectors of energy services, applied technology, media & consumer, medical & healthcare and real estate.

Despite a strong performance in major stock markets, unemployment in the western economies has continued to rise and the available liquidity has been predominantly a function of governments' monetary intervention. Whilst equity markets have shown short term gains, we believe there has been little evidence of a sustained recovery. The volume of private equity and real estate transactions remains low. For the immediate future we remain cautious.

The unaudited net asset value per share at 30 September 2009 was 87 pence, an increase of 5% since 30 June 2009 and a decrease of 2% from 31 December 2008. The principal factor in this increase was the recovery in the public markets. During October we have however seen a weakening in the share prices of our two largest quoted investments, ProStrakan Group and Weatherford International, and this, coupled with a slight strengthening of the US dollar over the same period, means that we estimate that NAV per share at the end of October had fallen back to its end of June level of 83 pence.

During the three months ended 30 September 2009 funds invested by the Company were 10.5 million in unquoted securities and to meet fund calls. Proceeds from realisations of quoted securities and fund distributions were 6.5 million.

The Company's investment portfolio at 30 September 2009 was as follows:

US UK Total GBP'000 % GBP'000 % GBP'000 % Quoted 39,539 18% 23,730 11% 63,269 29% Unquoted 16,275 7% 38,785 18% 55,060 25% Funds 72,248 33% 29,133 13% 101,381 46% Total 128,062 58% 91,648 42% 219,710 100%

The carrying value of the portfolio at 30 September 2009 is based on the valuation of the Company's investment portfolio as at 30 June 2009 with adjustments for transactions in the three months ended 30 September 2009 including price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds and purchases and sales of quoted securities. In addition, where the Company has invested further amounts in its existing unquoted portfolio, such amounts have been written off as fair value adjustments in the period and investments in new unquoted securities in the period are included at cost. The next full valuation of the portfolio will be as at 31 December 2009.

The ten largest holdings at 30 September 2009 (excluding fund interests where the Company has only a minority position) were as follows:

Name Geography Type Book value % of net assets GBP'000 Weatherford US Quoted 26,415 11% International Oilfield services Prostrakan Group plc UK Quoted 21,650 9% Specialty pharmaceuticals Method Products US Fund portfolio 10,963 8% Consumer products company Rave Reviews Cinemas US Unquoted 6,210 3% Cinema operations Updata Infrastructure UK Unquoted 6,200 3% UK Wide area networks Kizoom Transport UK Unquoted 6,000 3% information systems Wesupply B2B UK Unquoted 5,500 2% connectivity software Penguin Computing US Fund portfolio 5,345 2% Linux server systems company Gulfmark Offshore US Quoted 5,084 2% Offshore services Yes To Consumer US Fund portfolio 3,857 2% products company 97,224 45%

At 30 September 2009 the Company had uncalled commitments to funds of 62.6 million which we expect to be called over the next five years. Cash and other liquid assets (including the value of our quoted portfolio) were 84.7 million. The Company has no debt.

Portfolio subsidiaries

The latest available trading results for our portfolio subsidiaries are to 30 September and these indicate that 2009 continues to produce mixed results. Updata, in which we acquired our interest in July this year, has performed well and its results to September are ahead of budget. Entuity, our network management software business, is also trading ahead of budget with significantly improved profitability. Kizoom and Coppereye have encountered difficult trading conditions in 2009 and their results for the period have been disappointing. Members of our investment team are working closely with the management of these companies to achieve improvements in their operating performance.

This statement is a general description of the financial position and performance of the Company for the period from 1 July 2009 to 31 October 2009. It does not contain any profit forecast or forward looking information. Future performance and share price is likely to be affected by a number of factors, including (but not limited to) general economic and market conditions and specific factors affecting the financial performance or prospects of individual investments within the Company's portfolio.

vendor
Date   Source Headline
1st Jun 20187:00 amRNSExercise of Warrants
1st May 20185:35 pmRNSAuthorisation of Gresham House AM as AIFM
27th Apr 20183:50 pmRNSResults of 2018 Annual General Meeting
27th Apr 20187:00 amRNS1st Quarter 2018 update
26th Apr 20184:34 pmRNSHolding(s) in Company
5th Apr 20184:17 pmRNSDirector/PDMR Shareholding
29th Mar 201812:00 pmRNSAnnual Report and Notice of Annual General Meeting
26th Mar 201812:40 pmRNSReceipt of proceeds from Brockton Capital LLP
15th Mar 20187:00 amRNSAnnual Financial Report
8th Feb 201810:29 amRNSHolding(s) in Company
8th Feb 20187:00 amRNSSale of Investment
24th Jan 20187:00 amRNSNet Asset Value Estimate as at 31 December 2017
4th Jan 20189:01 amRNSKey Information Document Announcement
19th Dec 20173:14 pmRNSHolding(s) in Company
15th Dec 20174:40 pmRNSSecond Price Monitoring Extn
15th Dec 20174:35 pmRNSPrice Monitoring Extension
7th Dec 201712:22 pmRNSHolding(s) in Company
27th Oct 20173:57 pmRNSDirector/PDMR Shareholding
26th Oct 20177:00 amRNS3rd Quarter 2017 update
6th Sep 20175:19 pmRNSHolding(s) in Company
6th Sep 20175:16 pmRNSHolding(s) in Company
6th Sep 20175:13 pmRNSHolding(s) in Company
6th Sep 20175:09 pmRNSHolding(s) in Company
6th Sep 20177:00 amRNSDirector/PDMR Shareholding
25th Aug 201712:12 pmRNSHolding(s) in Company
25th Aug 201712:10 pmRNSHolding(s) in Company
23rd Aug 20173:55 pmRNSDirector/PDMR Shareholding
22nd Aug 20174:21 pmRNSDirector/PDMR Shareholding
22nd Aug 20174:17 pmRNSDirector/PDMR Shareholding
15th Aug 20173:55 pmRNSPurchase of Own Shares and Total Voting Rights
15th Aug 20179:15 amRNSResults of Tender Offer
11th Aug 20171:42 pmRNSResults of General Meeting
26th Jul 20177:01 amRNSTender Offer
26th Jul 20177:00 amRNSHalf Year Results for Six Months to 30 June 2017
20th Jul 201712:00 pmRNSHolding(s) in Company
18th Jul 201710:38 amRNSHolding(s) in Company
27th Jun 20177:00 amRNSIncrease in Tender Offer
15th Jun 201710:18 amRNSNotification of proceeds of fund distribution
6th Jun 20177:00 amRNSReview of Liquid Resources & Proposed Tender Offer
2nd Jun 20174:17 pmRNSHolding(s) in Company
25th May 20174:16 pmRNS2017 Annual General Meeting
22nd May 20177:00 amRNS1st Quarter 2017 Update
21st Apr 20177:00 amRNS2016 Annual Report and Notice of 2017 AGM
19th Apr 20173:39 pmRNSHolding(s) in Company
6th Apr 20176:29 pmRNSHolding(s) in Company
6th Apr 20177:00 amRNSSale of Majority Stake in 365IT to CORETX
14th Mar 20177:00 amRNSPreliminary Results
25th Jan 20177:00 amRNSNet Asset Value Estimate/ Progress on Realisations
18th Nov 201610:49 amPRNChange of Auditor
11th Nov 201610:55 amPRNPDMR Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.